2j95: Difference between revisions

No edit summary
No edit summary
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:2j95.jpg|left|200px]]


{{Structure
==CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX==
|PDB= 2j95 |SIZE=350|CAPTION= <scene name='initialview01'>2j95</scene>, resolution 2.01&Aring;
<StructureSection load='2j95' size='340' side='right'caption='[[2j95]], [[Resolution|resolution]] 2.01&Aring;' scene=''>
|SITE= <scene name='pdbsite=AC1:Ca+Binding+Site+For+Chain+A'>AC1</scene>
== Structural highlights ==
|LIGAND= <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene> and <scene name='pdbligand=GSX:5&#39;-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-2,2&#39;-BITHIOPHENE-5-SULFONAMIDE'>GSX</scene>
<table><tr><td colspan='2'>[[2j95]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2J95 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2J95 FirstGlance]. <br>
|ACTIVITY= [http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6]  
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.01&#8491;</td></tr>
|GENE=  
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=GSX:5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-2,2-BITHIOPHENE-5-SULFONAMIDE'>GSX</scene></td></tr>
}}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2j95 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2j95 OCA], [https://pdbe.org/2j95 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2j95 RCSB], [https://www.ebi.ac.uk/pdbsum/2j95 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2j95 ProSAT]</span></td></tr>
</table>
== Disease ==
[https://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN] Defects in F10 are the cause of factor X deficiency (FA10D) [MIM:[https://omim.org/entry/227600 227600]. A hemorrhagic disease with variable presentation. Affected individuals can manifest prolonged nasal and mucosal hemorrhage, menorrhagia, hematuria, and occasionally hemarthrosis. Some patients do not have clinical bleeding diathesis.<ref>PMID:2790181</ref> <ref>PMID:1973167</ref> <ref>PMID:1985698</ref> <ref>PMID:7669671</ref> <ref>PMID:8529633</ref> <ref>PMID:7860069</ref> <ref>PMID:8845463</ref> <ref>PMID:8910490</ref> <ref>PMID:10468877</ref> <ref>PMID:10746568</ref> <ref>PMID:10739379</ref> <ref>PMID:11248282</ref> <ref>PMID:11728527</ref> <ref>PMID:12945883</ref> <ref>PMID:15650540</ref> <ref>PMID:17393015</ref> <ref>PMID:19135706</ref>
== Function ==
[https://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN] Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/j9/2j95_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2j95 ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Factor Xa inhibitory activities for a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl }sulfonamides with different P1 groups are described. These data provide insight into binding interactions within the S1 primary specificity pocket; rationales are presented for the derived SAR on the basis of electronic interactions through crystal structures of fXa-ligand complexes and molecular modeling studies. A good correlation between in vitro anticoagulant activities with lipophilicity and the extent of human serum albumin binding is observed within this series of potent fXa inhibitors. Pharmacokinetic profiles in rat and dog, together with selectivity over other trypsin-like serine proteases, identified 1f as a candidate for further evaluation.


'''CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX'''
Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl }sulfonamides.,Chan C, Borthwick AD, Brown D, Burns-Kurtis CL, Campbell M, Chaudry L, Chung CW, Convery MA, Hamblin JN, Johnstone L, Kelly HA, Kleanthous S, Patikis A, Patel C, Pateman AJ, Senger S, Shah GP, Toomey JR, Watson NS, Weston HE, Whitworth C, Young RJ, Zhou P J Med Chem. 2007 Apr 5;50(7):1546-57. Epub 2007 Mar 6. PMID:17338508<ref>PMID:17338508</ref>


From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 2j95" style="background-color:#fffaf0;"></div>


==Disease==
==See Also==
Known disease associated with this structure: Factor X deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227600 227600]]
*[[Factor Xa|Factor Xa]]
 
== References ==
==About this Structure==
<references/>
2J95 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2J95 OCA].
__TOC__
[[Category: Coagulation factor Xa]]
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Borthwick, A D.]]
[[Category: Borthwick AD]]
[[Category: Brown, D.]]
[[Category: Brown D]]
[[Category: Burns-Kurtis, C L.]]
[[Category: Burns-Kurtis CL]]
[[Category: Campbell, M.]]
[[Category: Campbell M]]
[[Category: Chan, C.]]
[[Category: Chan C]]
[[Category: Chaudry, L.]]
[[Category: Chaudry L]]
[[Category: Chung, C W.]]
[[Category: Chung CW]]
[[Category: Convery, M A.]]
[[Category: Convery MA]]
[[Category: Hamblin, J N.]]
[[Category: Hamblin JN]]
[[Category: Johnstone, L.]]
[[Category: Johnstone L]]
[[Category: Kelly, H A.]]
[[Category: Kelly HA]]
[[Category: Kleanthous, S.]]
[[Category: Kleanthous S]]
[[Category: Patel, C.]]
[[Category: Patel C]]
[[Category: Pateman, A J.]]
[[Category: Pateman AJ]]
[[Category: Patikis, A.]]
[[Category: Patikis A]]
[[Category: Senger, S.]]
[[Category: Senger S]]
[[Category: Shah, G P.]]
[[Category: Shah GP]]
[[Category: Toomey, J R.]]
[[Category: Toomey JR]]
[[Category: Watson, N S.]]
[[Category: Watson NS]]
[[Category: Weston, H E.]]
[[Category: Weston HE]]
[[Category: Whitworth, C.]]
[[Category: Whitworth C]]
[[Category: Young, R J.]]
[[Category: Young RJ]]
[[Category: Zhou, P.]]
[[Category: Zhou P]]
[[Category: CA]]
[[Category: GSX]]
[[Category: blood coagulation]]
[[Category: calcium]]
[[Category: complex]]
[[Category: egf-like domain]]
[[Category: gamma-carboxyglutamic acid]]
[[Category: glycoprotein]]
[[Category: hydrolase]]
[[Category: hydroxylation]]
[[Category: polymorphism]]
[[Category: protease]]
[[Category: serine protease]]
[[Category: zymogen]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 23 15:25:00 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA